A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771.

Source:http://linkedlifedata.com/resource/pubmed/id/7988246

Download in:

View as

General Info

PMID
7988246